These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637 [TBL] [Abstract][Full Text] [Related]
3. In vitro study of bacterial growth in continuous ambulatory peritoneal dialysis fluids. Sheth NK; Bartell CA; Roth DA J Clin Microbiol; 1986 Jun; 23(6):1096-8. PubMed ID: 3086376 [TBL] [Abstract][Full Text] [Related]
4. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Buggy BP; Schaberg DR; Swartz RD Am J Med; 1984 Jun; 76(6):1035-40. PubMed ID: 6731461 [TBL] [Abstract][Full Text] [Related]
5. Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages. de Fijter CW; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Donker AJ; Verhoef J J Antimicrob Chemother; 1990 Oct; 26(4):525-32. PubMed ID: 2254222 [TBL] [Abstract][Full Text] [Related]
6. Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis. de Fijter CW; Oe LP; Heezius EC; Donker AJ; Verbrugh HA Am J Kidney Dis; 1996 Mar; 27(3):409-15. PubMed ID: 8604711 [TBL] [Abstract][Full Text] [Related]
7. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli. Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756 [TBL] [Abstract][Full Text] [Related]
8. In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids. Halstead DC; Guzzo J; Giardina JA; Geshan AE Antimicrob Agents Chemother; 1989 Sep; 33(9):1553-6. PubMed ID: 2510594 [TBL] [Abstract][Full Text] [Related]
9. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients. Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399 [TBL] [Abstract][Full Text] [Related]
10. Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid. Dasgupta MK; Ward K; Noble PA; Larabie M; Costerton JW Am J Kidney Dis; 1994 May; 23(5):709-16. PubMed ID: 8172213 [TBL] [Abstract][Full Text] [Related]
11. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli. Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538 [TBL] [Abstract][Full Text] [Related]